NovoCure Ltd (NASDAQ: NVCR) open the trading on Wednesday, with a bit cautious approach as it glided -4.64% to $12.33, before settling in for the price of $12.93 at the close. Taking a more long-term approach, NVCR posted a 52-week range of $10.70-$34.13.
The Healthcare sector firm’s twelve-monthly sales growth has been -83.87% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -83.87%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 10.10%. This publicly-traded company’s shares outstanding now amounts to $111.98 million, simultaneously with a float of $100.42 million. The organization now has a market capitalization sitting at $1.38 billion. At the time of writing, stock’s 50-day Moving Average stood at $12.64, while the 200-day Moving Average is $15.04.
NovoCure Ltd (NVCR) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Medical Devices industry. NovoCure Ltd’s current insider ownership accounts for 10.33%, in contrast to 82.92% institutional ownership. According to the most recent insider trade that took place on Sep 05 ’25, this organization’s Chief Executive Officer bought 81,550 shares at the rate of 12.22, making the entire transaction reach 996,859 in total value, affecting insider ownership by 437,569. Preceding that transaction, on Jul 29 ’25, Company’s Chief Financial Officer bought 20,000 for 11.59, making the whole transaction’s value amount to 231,800. This particular insider is now the holder of 141,150 in total.
NovoCure Ltd (NVCR) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.37 per share during the current fiscal year.
NovoCure Ltd’s EPS increase for this current 12-month fiscal period is 10.10% and is forecasted to reach -1.49 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 13.08% through the next 5 years, which can be compared against the -83.87% growth it accomplished over the previous five years trading on the market.
NovoCure Ltd (NASDAQ: NVCR) Trading Performance Indicators
Let’s observe the current performance indicators for NovoCure Ltd (NVCR). It’s Quick Ratio in the last reported quarter now stands at 1.50. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.15.
In the same vein, NVCR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.61, a figure that is expected to reach -0.40 in the next quarter, and analysts are predicting that it will be -1.49 at the market close of one year from today.
Technical Analysis of NovoCure Ltd (NVCR)
[NovoCure Ltd, NVCR] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 51.82% While, its Average True Range was 46.64.
Raw Stochastic average of NovoCure Ltd (NVCR) in the period of the previous 100 days is set at 40.10%, which indicates a major fall in contrast to 48.89% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.65 that was higher than 0.57 volatility it exhibited in the past 100-days period.
